Engineered and designed by CRB, Pfizer’s Andover Clinical Manufacturing Facility focuses on integration and flexibility to speed patient therapies.
Press Release
April 28, 2020 /3BL Media/ - A state-of-the-art facility allowing Pfizer Inc. to significantly expand its global clinical manufacturing and speed critical therapies to patients has been awarded the 2020 Facility of the Year Award for Facility Integration, by the International Society for Pharmaceutical Engineering.
Building on Pfizer’s longstanding commitment to fight infectious diseases, grants will help address urgent needs of U.S. and global partners on the front lines of the pandemic
Donations complement Pfizer’s COVID-19 R&D investments, as well as collective scientific and philanthropic contributions made by the biopharmaceutical industry
U.S. Patient Assistance Program and other programs respond to changing needs of patients and medical community
Press Release
Building on Pfizer’s longstanding commitment to fight infectious diseases, grants will help address urgent needs of U.S. and global partners on the front lines of the pandemic
Donations complement Pfizer’s COVID-19 R&D investments, as well as collective scientific and philanthropic contributions made by the biopharmaceutical industry
U.S. Patient Assistance Program and other programs respond to changing needs of patients and medical community
Today on International Day of Rural Women, Pfizer is reflecting on its work with partners – including CARE, International Rescue Committee, Save the Children and World Vision – to strengthen health systems and empower women in rural areas. Through the Pfizer Foundation* Healthy Families, Healthy Futures program, women in rural communities are receiving access to quality family planning and immunization services, which in turn allows them to prioritize their futures.
African Americans are disproportionately affected by many diseases and Pfizer is committed to improving health among this segment of the population through science, partnerships, insights and expertise.
Three Virtues is our integrated, enterprise-wide initiative aiming to:
The Pfizer Foundation* announced today 20 grants to help non-governmental organizations (NGOs), non-profits and social enterprises address critical health challenges related to infectious diseases, including the increasing threat of antimicrobial resistance (AMR), in some of the world’s most vulnerable communities. Recipients of the one-year Global Health Innovation Grants (GHIG) include partners in 12 low- and middle-income countries that will each receive US $100,000, for a total investment this year of US $2 million by The Pfizer Foundation.
At Pfizer, we discover and develop novel vaccines that help protect people around the world from deadly viruses and bacteria. In 2018, we focused on rational vaccine design — understanding the structure of proteins enabled by high-tech tools like cryo-electron microscopy as a basis to design and produce those proteins for use in vaccines.
July 2, 2019 /3BL Media/ Today Pfizer Australia hosts a gathering of 40 of its non-traditional industry partners to discuss volunteerism and potential collaborative efforts with the United Nations, corporations, nonprofits, academia, and other stakeholders to address Australia’s needs as part of the
Corporate Social Responsibility Software Leader Recognizes Clients Patagonia, Pfizer, and Wells Fargo
Press Release
NASHVILLE, Tenn., July 1, 2019 /3BL Media/ - CyberGrants, the leading provider of corporate social responsibility software, today announced the winners of the Ovation Awards at their annual Social Impact Leadership Conference in Nashville. Recognizing organizations for their contributions and deep commitment to philanthropic excellence, vision, and inspirational social impact, the company is honored to announce this years’ recipients: Patagonia, Pfizer compassionate access program PfizerCAReS, and Wells Fargo.
Pfizer is committed to ensuring that the manufacturing, use and disposal of our products, including antibiotics, does not adversely affect human health or the environment. Core to this commitment is taking action to assess and reduce, as needed, the risk of antibiotics in wastewater from Pfizer and supplier manufacturing facilities
